Aerpio Pharmaceuticals, Inc.
ARPO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $151,983 | $59,466 | $59,466 |
| - Cash | $37,931 | $144,936 | $227,569 | $28,670 |
| + Debt | $0 | $0 | $0 | $833 |
| Enterprise Value | – | $7,047 | -$168,103 | $31,629 |
| Revenue | $0 | $0 | $7,145 | $22,982 |
| % Growth | – | -100% | -68.9% | – |
| Gross Profit | $0 | $0 | $0 | $22,840 |
| % Margin | – | – | 0% | 99.4% |
| EBITDA | -$17,746 | -$54,749 | -$15,218 | -$36,826 |
| % Margin | – | – | -213% | -160.2% |
| Net Income | -$17,746 | -$52,615 | $73,016 | -$14,493 |
| % Margin | – | – | 1,021.9% | -63.1% |
| EPS Diluted | -0.26 | -0.76 | 2.7 | -1.04 |
| % Growth | 65.8% | -128.1% | 359.6% | – |
| Operating Cash Flow | -$15,378 | -$52,957 | -$11,864 | -$20,233 |
| Capital Expenditures | $0 | -$1 | -$551 | $4,090 |
| Free Cash Flow | -$15,378 | -$52,958 | -$12,415 | -$16,143 |